Bio-Techne
Stock Forecast, Prediction & Price Target
Bio-Techne (TECH) stock Price Target by analysts
$82
Potential upside: 49.63%
Bio-Techne price prediction
What is Bio-Techne stock analysts` prediction?
Bio-Techne stock forecast: Based on 2 Wall Street analysts` predicted price targets for Bio-Techne in the last 3 months, the avarage price target is $82, with a high forecast of $NaN. The average price target represents a 49.63% change from the last price of $54.8.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Bio-Techne stock Price Target by analysts
Full breakdown of analysts given Bio-Techne price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Catherine Schulte Robert W. Baird | 0% 0/1 | 10 months ago | $84 53.28% upside | $76.02 | StreetInsider | Previous targets (0) |
Paul Knight KeyBanc | 0% 0/2 | 10 months ago | $80 45.98% upside | $76.02 | StreetInsider | Previous targets (1) |
Sung Ji Nam Scotiabank | 0% 0/1 | about 1 year ago | $83 51.45% upside | $74.19 | StreetInsider | Previous targets (0) |
Unknown Deutsche Bank | N/A | over 2 years ago | $100 82.48% upside | $86.98 | Benzinga | N/A |
Unknown Citigroup | N/A | over 2 years ago | $100 82.48% upside | $80.73 | Benzinga | N/A |
Unknown RBC Capital | N/A | over 2 years ago | $89 62.40% upside | $80.67 | Benzinga | N/A |
Unknown Stephens | N/A | almost 3 years ago | $105 91.60% upside | $82.44 | Benzinga | N/A |
Paul Knight KeyBanc | 0% 0/2 | over 3 years ago | $500 812.40% upside | $395.84 | Pulse 2.0 | Previous targets (1) |
Patrick B Donnelly Citigroup | 100% 1/1 | over 4 years ago | $425 675.54% upside | $409.79 | StreetInsider | Previous targets (0) |
Bio-Techne Financial Estimates
Bio-Techne Revenue Estimates
Bio-Techne EBITDA Estimates
Bio-Techne Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 6/30/2022 | 6/30/2023 | 6/30/2024 | 6/30/2026 | 6/30/2027 | 6/30/2028 | |
Revenue
% change YoY
| $1.10B N/A | $1.13B 2.81% | $1.15B 1.96% | Avg: $1.37B Low: $1.36B High: $1.39B avg. 19.02% | Avg: $1.52B Low: $1.50B High: $1.54B avg. 10.61% | Avg: $2.12B Low: $2.09B High: $2.14B avg. 39.26% | |
Net Income
% change YoY
| $272.05M N/A | $285.26M 4.85% | $168.10M -41.07% | Avg: $271.13M Low: $267.06M High: $275.15M avg. 61.29% | Avg: $343.08M Low: $335.75M High: $345.70M avg. 26.53% | Avg: $0 Low: $0 High: $0 avg. -100% | |
EBITDA
% change YoY
| $397.65M N/A | $460.56M 15.81% | $310.37M -32.61% | Avg: $383.66M Low: $378.68M High: $387.28M avg. 23.61% | Avg: $424.37M Low: $418.87M High: $428.38M avg. 10.61% | Avg: $591.01M Low: $583.34M High: $596.59M avg. 39.26% | |
EPS
% change YoY
| $1.73 N/A | $1.81 4.62% | $1.07 -40.88% | Avg: $1.67 Low: $1.65 High: $1.7 avg. 55.88% | Avg: $2.11 Low: $2.07 High: $2.14 avg. 26.49% | Avg: $0 Low: $0 High: $0 avg. -100% | |
Operating Expenses
% change YoY
| $459.90M N/A | $470.87M 2.38% | $563.03M 19.57% | Avg: $480.67M Low: $474.43M High: $485.21M avg. -14.62% | Avg: $531.68M Low: $524.78M High: $536.70M avg. 10.61% | Avg: $740.46M Low: $730.84M High: $747.45M avg. 39.26% | |
FAQ
What is Bio-Techne stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 29.27% in 2026-2028.
We have gathered data from 5 analysts. Their low estimate is 267.06M, average is 271.13M and high is 275.15M.
What is Bio-Techne stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 22.96% in 2026-2028.
We have gathered data from 11 analysts. Their low revenue estimate is $1.36B, average is $1.37B and high is $1.39B.
What is Bio-Techne stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 27.46% in 2026-2028.
We have gathered data from 5 analysts. Their low earnings per share estimate is $1.65, average is $1.67 and high is $1.7.
What is the best performing analyst?
In the last twelve months 2 analysts have been covering Bio-Techne stock. The most successful analyst is Catherine Schulte.